ABIVAX

A French Société anonyme (corporation) with a capital of 629,308.18 euros

Registered office: 7-11, boulevard Haussmann

75009 Paris (France)

Paris Trade and Companies Registry no. 799 363 718

Annual Ordinary and Extraordinary General Shareholders' Meeting on 30 May 2024

Breakdown of the vote by resolution

Number of shares with voting rights

61 012 501

Total number of votes

68 032 059

Number of shareholders present, represented or voting by post

132

Number of shares present, represented or voting by post

49 815 120

Number of votes present, represented or voting by post

55 747 104

Participation rate

81.65%

For

Against

Abstain

Ordinary General Shareholders' Meeting

Votes

%

Votes

%

Votes

%

1.

Approval of the Company's financial statements for

the financial

year

55 730 237

99.999%

494

0.001%

16 373

0.029%

ended 31 December 2023

2.

Approval of the Company's consolidated financial

statements for

the

55 730 237

99.999%

494

0.001%

16 373

0.029%

financial year ended 31 December 2023

3.

Allocation of the income for the financial year ended 31 December 2023

55 746 610

99.999%

494

0.001%

0

0.000%

4.

Approval of the agreements referred to Articles L. 225-38 et seq. of the

44 083 418

79.078%

11 663 486

20.922%

200

0.001%

French Commercial Code (Code de commerce)

5.

Ratification of the cooptation of a Director (Troy Ignelzi)

55 707 725

99.930%

39 179

0.070%

200

0.001%

6.

Ratification of the cooptation of a Director (June (Lee) Kim)

55 707 725

99.930%

39 179

0.070%

200

0.001%

7.

Ratification of the cooptation of a Director (Camilla Soenderby)

55 746 324

99.999%

580

0.001%

200

0.001%

8.

Approval of the compensation items mentioned in Article L. 22-10-9 I of

the French Commercial Code, pursuant to Article L. 22-10-34 of the French

54 504 460

97.771%

1 242 444

2.229%

200

0.001%

Commercial Code

For

Against

Abstain

Ordinary General Shareholders' Meeting

Votes

%

Votes

%

Votes

%

9.

Approval of the compensation items paid during, or allocated for, the

financial year 2023 to Ms. Corinna zur Bonsen-Thomas as Chair of the

55 594 011

99.726%

152 893

0.274%

200

0.001%

Board of Directors by interim

10.

Approval of the compensation items paid during, or allocated for, the

financial year 2023 to Mr. Marc de Garidel as Chairman of the Board of

44 137 875

79.175%

11 609 029

20.825%

200

0.001%

Directors and Chief Executive Officer

11.

Approval of the compensation items paid during, or allocated for, the

44 056 505

79.030%

11 690 399

20.970%

200

0.001%

financial year 2023 to Mr. Hartmut Ehrlich as Chief Executive Officer

12.

Approval of the information on corporate officers' compensation included

in the corporate governance report and referred to in Article L.22-10-9 I.

54 655 224

98.042%

1 091 680

1.958%

200

0.001%

of the French Commercial Code

13.

Approval of the compensation policy applicable to the Chairman of the

55 744 775

99.996%

2 129

0.004%

200

0.001%

Board of Directors

14.

Approval of the compensation policy applicable to the Chief Executive

44 256 935

79.389%

11 489 969

20.611%

200

0.001%

Officer

15.

Approval of the compensation policy applicable to the Board members

55 594 011

99.726%

152 893

0.274%

200

0.001%

16.

Authorization to be granted to the Board to purchase the Company's own

44 593 043

79.992%

11 153 861

20.008%

200

0.001%

shares

For

Against

Abstain

Extraordinary General Shareholders' Meeting

Votes

%

Votes

%

Votes

%

17.

Authorization to the Board of Directors to reduce share capital by

55 444 282

99.457%

302 622

0.543%

200

0.001%

cancelling treasury shares

18.

Delegation of authority to the Board of Directors to carry out a capital

increase by issuing shares, equity securities giving access to other equity

securities or giving the right to the allocation of debt securities and/or

44 183 811

79.258%

11 563 093

20.742%

200

0.001%

securities giving access to equity securities, maintaining preferential

subscription rights

19.

Delegation of authority to the Board of Directors to carry out a capital

increase by issuing shares, equity securities giving access to other equity

44 034 819

78991%

11 712 085

21.009%

200

0.001%

securities or giving the right to the allocation of debt securities and/or

securities giving access to equity securities, with cancellation of the

For

Against

Abstain

Extraordinary General Shareholders' Meeting

Votes

%

Votes

%

Votes

%

preferential subscription rights by way of an offer to the public, and with

the ability to confer a right of priority

20.

Delegation of authority to the Board of Directors to carry out a capital

increase by issuing shares, equity securities giving access to other equity

securities or giving the right to the allocation of debt securities and/or

44 035 900

78.993%

11 711 004

21.007%

200

0.001%

securities giving access to equity securities, with cancellation of the

preferential subscription rights in favor of a specific category of persons

21.

Delegation of authority to the Board of Directors to carry out a capital

increase, within the limit of 20% of the share capital per year, by issuing

shares, equity securities conferring access to other equity securities or

conferring the right to an allotment of debt securities and/or securities

44 629 521

80.057%

11 117 383

19.943%

200

0.001%

conferring access to equity securities, with cancellation of the preferential

subscription rights by way of an offer to qualified investors or a restricted

group of investors, within the meaning of Article L. 411-2, paragraph II, of

the French Monetary and Financial Code (Code monétaire et financier)

22.

Authorization to be granted to the Board of Directors in accordance with

Articles L. 22-10-52, paragraph 2, and R. 22-10-32 of the French

Commercial Code to set the issue price of the shares, equity securities

conferring access to other equity securities or conferring the right to an

44 223 534

79.329%

11 523 370

20.671%

200

0.001%

allotment of debt securities and/or securities conferring access to equity

securities, with cancellation of the preferential subscription rights, for the

delegations of authority set forth in the 19th and 21st resolutions

23.

Delegation of authority to the Board of Directors to carry out a capital

increase by issuing shares, equity securities conferring access to other

equity securities or conferring the right to an allotment of debt securities

and/or securities conferring access to equity securities, with cancellation of

44 074 499

79.062%

11 672 405

20.938%

200

0.001%

the preferential subscription rights in favor of certain categories of

investors within the framework of an equity financing agreement in the

United States stock market known as an "At-The-Market" or "ATM

Program"

24.

Delegation of authority to the Board of Directors to increase the number of

shares to be issued in the event of a capital increase with or without

44 309 207

79.483%

11 437 697

20.517%

200

0.001%

preferential subscription rights

25.

Delegation of authority to the Board of Directors to increase capital by

55 626 350

99.784%

120 554

0.216%

200

0.001%

capitalizing premiums, reserves, profits or other items

For

Against

Abstain

Extraordinary General Shareholders' Meeting

Votes

%

Votes

%

Votes

%

26.

Delegation of authority to the Board of Directors to issue shares and

securities leading to a capital increase in consideration of non-cash

44 073 640

79.060%

11 673 264

20.940%

200

0.001%

contributions

27.

Delegation of authority to the Board of Directors to issue shares and

securities entailing a capital increase in the event of a public exchange offer

44 035 041

78.991%

11 711 863

21.009%

200

0.001%

initiated by the Company

28.

Setting of the overall limits on the amount of the issues carried out pursuant

55 550 917

99.648%

195 987

0.352%

200

0.001%

to the delegations granted

29.

Authorization to the Board of Directors to grant share subscription and/or

purchase options ("Options"), with cancellation of the shareholders'

44 009 664

78.945%

11 737 240

21.055%

200

0.001%

preferential subscription rights in favor of a specific category of persons

30.

Delegation of authority to the Board of Directors to issue and allot ordinary

share warrants ("Warrants"), with cancellation of the shareholders'

44 049 263

79.017%

11 697 641

20.983%

200

0.001%

preferential subscription rights in favor of a specific category of persons

31.

Authorization to the Board of Directors to allot free shares, whether

existing or to be issued ("Free Shares"), with cancellation of the

44 165 912

79.226%

11 580 992

20.774%

200

0.001%

shareholders' preferential subscription rights in favor of a specific category

of persons

32.

Setting of the overall limits on the amount of the issues carried out pursuant

to the authorizations to grant Options and Free Shares and the delegations

55 704 647

99.924%

42 257

0.076%

200

0.001%

of authority in order to issue Warrants

33.

Delegation of authority to the Board of Directors to carry out a capital

increase by issuing shares or securities conferring access to the Company's

32 655 576

58.578%

23 091 328

41.422%

200

0.001%

capital restricted to members of a company savings plan, with cancellation

of the shareholders' preferential subscription rights in favor thereof

For

Against

Abstain

Ordinary General Shareholders' Meeting

Votes

%

Votes

%

Votes

%

34.

Powers for formalities

55 746 410

99.999%

494

0.001%

200

0.001%

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Abivax SA published this content on 04 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 June 2024 20:29:48 UTC.